HEADER TRANSFERASE/TRANSFERASE INHIBITOR 06-APR-16 5J7H OBSLTE 12-DEC-18 5J7H 6MX8 TITLE CRYSTAL STRUCTURE OF ANAPLASTIC LYMPHOMA KINASE (ALK) BOUND BY TITLE 2 BRIGATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALK TYROSINE KINASE RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1093-1407; COMPND 5 SYNONYM: ANAPLASTIC LYMPHOMA KINASE; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ALK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS RECEPTOR TYROSINE KINASE, SMALL MOLECULE INHIBITOR, TARGETED THERAPY, KEYWDS 2 CANCER, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR T.ZHOU,L.PARILLON,X.ZHU,D.C.DALGARNO REVDAT 3 12-DEC-18 5J7H 1 OBSLTE JRNL REMARK REVDAT 2 08-JUN-16 5J7H 1 JRNL REVDAT 1 25-MAY-16 5J7H 0 JRNL AUTH W.S.HUANG,S.LIU,D.ZOU,M.THOMAS,Y.WANG,T.ZHOU,J.ROMERO, JRNL AUTH 2 A.KOHLMANN,F.LI,J.QI,L.CAI,T.A.DWIGHT,Y.XU,R.XU,R.DODD, JRNL AUTH 3 A.TOMS,L.PARILLON,X.LU,R.ANJUM,S.ZHANG,F.WANG,J.KEATS, JRNL AUTH 4 S.D.WARDWELL,Y.NING,Q.XU,L.E.MORAN,Q.K.MOHEMMAD,H.G.JANG, JRNL AUTH 5 T.CLACKSON,N.I.NARASIMHAN,V.M.RIVERA,X.ZHU,D.DALGARNO, JRNL AUTH 6 W.C.SHAKESPEARE JRNL TITL DISCOVERY OF BRIGATINIB (AP26113), A PHOSPHINE JRNL TITL 2 OXIDE-CONTAINING, POTENT, ORALLY ACTIVE INHIBITOR OF JRNL TITL 3 ANAPLASTIC LYMPHOMA KINASE. JRNL REF J.MED.CHEM. V. 59 4948 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27144831 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00306 REMARK 2 REMARK 2 RESOLUTION. 1.96 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.96 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.8 REMARK 3 NUMBER OF REFLECTIONS : 21600 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.500 REMARK 3 FREE R VALUE TEST SET COUNT : 1038 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2290 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 70 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 43.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.12400 REMARK 3 B22 (A**2) : 0.25400 REMARK 3 B33 (A**2) : -0.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.235 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.041 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.920 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.849 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : 113_CHARM2.PARAM REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5J7H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219724. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU ULTRAX 18 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23040 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.960 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.20 REMARK 200 R MERGE FOR SHELL (I) : 0.70300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS, CNS REMARK 200 STARTING MODEL: 2XB7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.19 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS HCL PH 8.5, 19-27% PEG REMARK 280 3350, 2 MM TCEP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.94550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.99300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 28.75100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.99300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.94550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 28.75100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1089 REMARK 465 SER A 1090 REMARK 465 THR A 1091 REMARK 465 SER A 1092 REMARK 465 GLY A 1137 REMARK 465 MET A 1138 REMARK 465 PRO A 1139 REMARK 465 ASN A 1140 REMARK 465 ASP A 1141 REMARK 465 PRO A 1142 REMARK 465 ASP A 1276 REMARK 465 ILE A 1277 REMARK 465 TYR A 1278 REMARK 465 ARG A 1279 REMARK 465 ALA A 1280 REMARK 465 SER A 1281 REMARK 465 TYR A 1282 REMARK 465 TYR A 1283 REMARK 465 ARG A 1284 REMARK 465 LYS A 1285 REMARK 465 GLY A 1286 REMARK 465 GLY A 1287 REMARK 465 GLY A 1402 REMARK 465 PRO A 1403 REMARK 465 LEU A 1404 REMARK 465 VAL A 1405 REMARK 465 GLU A 1406 REMARK 465 GLU A 1407 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASP A 1107 O HOH A 1601 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 TYR A1401 CE2 TYR A1401 CD2 -0.090 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A1094 131.48 -32.84 REMARK 500 GLN A1217 73.43 -115.00 REMARK 500 ARG A1248 -8.26 79.97 REMARK 500 ASP A1249 46.69 -152.08 REMARK 500 LEU A1325 42.51 70.14 REMARK 500 SER A1332 -9.56 93.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A1401 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6GY A 1501 DBREF 5J7H A 1093 1407 UNP Q9UM73 ALK_HUMAN 1093 1407 SEQADV 5J7H GLY A 1089 UNP Q9UM73 EXPRESSION TAG SEQADV 5J7H SER A 1090 UNP Q9UM73 EXPRESSION TAG SEQADV 5J7H THR A 1091 UNP Q9UM73 EXPRESSION TAG SEQADV 5J7H SER A 1092 UNP Q9UM73 EXPRESSION TAG SEQRES 1 A 319 GLY SER THR SER ASN PRO ASN TYR CYS PHE ALA GLY LYS SEQRES 2 A 319 THR SER SER ILE SER ASP LEU LYS GLU VAL PRO ARG LYS SEQRES 3 A 319 ASN ILE THR LEU ILE ARG GLY LEU GLY HIS GLY ALA PHE SEQRES 4 A 319 GLY GLU VAL TYR GLU GLY GLN VAL SER GLY MET PRO ASN SEQRES 5 A 319 ASP PRO SER PRO LEU GLN VAL ALA VAL LYS THR LEU PRO SEQRES 6 A 319 GLU VAL CYS SER GLU GLN ASP GLU LEU ASP PHE LEU MET SEQRES 7 A 319 GLU ALA LEU ILE ILE SER LYS PHE ASN HIS GLN ASN ILE SEQRES 8 A 319 VAL ARG CYS ILE GLY VAL SER LEU GLN SER LEU PRO ARG SEQRES 9 A 319 PHE ILE LEU LEU GLU LEU MET ALA GLY GLY ASP LEU LYS SEQRES 10 A 319 SER PHE LEU ARG GLU THR ARG PRO ARG PRO SER GLN PRO SEQRES 11 A 319 SER SER LEU ALA MET LEU ASP LEU LEU HIS VAL ALA ARG SEQRES 12 A 319 ASP ILE ALA CYS GLY CYS GLN TYR LEU GLU GLU ASN HIS SEQRES 13 A 319 PHE ILE HIS ARG ASP ILE ALA ALA ARG ASN CYS LEU LEU SEQRES 14 A 319 THR CYS PRO GLY PRO GLY ARG VAL ALA LYS ILE GLY ASP SEQRES 15 A 319 PHE GLY MET ALA ARG ASP ILE TYR ARG ALA SER TYR TYR SEQRES 16 A 319 ARG LYS GLY GLY CYS ALA MET LEU PRO VAL LYS TRP MET SEQRES 17 A 319 PRO PRO GLU ALA PHE MET GLU GLY ILE PHE THR SER LYS SEQRES 18 A 319 THR ASP THR TRP SER PHE GLY VAL LEU LEU TRP GLU ILE SEQRES 19 A 319 PHE SER LEU GLY TYR MET PRO TYR PRO SER LYS SER ASN SEQRES 20 A 319 GLN GLU VAL LEU GLU PHE VAL THR SER GLY GLY ARG MET SEQRES 21 A 319 ASP PRO PRO LYS ASN CYS PRO GLY PRO VAL TYR ARG ILE SEQRES 22 A 319 MET THR GLN CYS TRP GLN HIS GLN PRO GLU ASP ARG PRO SEQRES 23 A 319 ASN PHE ALA ILE ILE LEU GLU ARG ILE GLU TYR CYS THR SEQRES 24 A 319 GLN ASP PRO ASP VAL ILE ASN THR ALA LEU PRO ILE GLU SEQRES 25 A 319 TYR GLY PRO LEU VAL GLU GLU HET 6GY A1501 40 HETNAM 6GY 5-CHLORO-N~4~-[2-(DIMETHYLPHOSPHORYL)PHENYL]-N~2~-{2- HETNAM 2 6GY METHOXY-4-[4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1- HETNAM 3 6GY YL]PHENYL}PYRIMIDINE-2,4-DIAMINE HETSYN 6GY BRIGATINIB FORMUL 2 6GY C29 H39 CL N7 O2 P FORMUL 3 HOH *70(H2 O) HELIX 1 AA1 SER A 1106 LEU A 1108 5 3 HELIX 2 AA2 PRO A 1112 LYS A 1114 5 3 HELIX 3 AA3 SER A 1157 PHE A 1174 1 18 HELIX 4 AA4 LEU A 1204 THR A 1211 1 8 HELIX 5 AA5 ALA A 1222 ASN A 1243 1 22 HELIX 6 AA6 ALA A 1251 ARG A 1253 5 3 HELIX 7 AA7 PRO A 1292 MET A 1296 5 5 HELIX 8 AA8 PRO A 1297 GLY A 1304 1 8 HELIX 9 AA9 THR A 1307 LEU A 1325 1 19 HELIX 10 AB1 SER A 1334 SER A 1344 1 11 HELIX 11 AB2 PRO A 1355 TRP A 1366 1 12 HELIX 12 AB3 GLN A 1369 ARG A 1373 5 5 HELIX 13 AB4 ASN A 1375 ASP A 1389 1 15 HELIX 14 AB5 ASP A 1389 ASN A 1394 1 6 SHEET 1 AA1 2 ASN A1095 PHE A1098 0 SHEET 2 AA1 2 LYS A1101 SER A1104 -1 O SER A1103 N TYR A1096 SHEET 1 AA2 5 ILE A1116 HIS A1124 0 SHEET 2 AA2 5 GLU A1129 VAL A1135 -1 O GLU A1132 N ILE A1119 SHEET 3 AA2 5 LEU A1145 THR A1151 -1 O LEU A1145 N VAL A1135 SHEET 4 AA2 5 PHE A1193 GLU A1197 -1 O LEU A1196 N ALA A1148 SHEET 5 AA2 5 CYS A1182 SER A1186 -1 N GLY A1184 O LEU A1195 SHEET 1 AA3 3 GLY A1202 ASP A1203 0 SHEET 2 AA3 3 CYS A1255 LEU A1257 -1 O LEU A1257 N GLY A1202 SHEET 3 AA3 3 ALA A1266 ILE A1268 -1 O LYS A1267 N LEU A1256 CISPEP 1 LEU A 1190 PRO A 1191 0 -3.30 SITE 1 AC1 9 LEU A1122 ALA A1148 LEU A1196 GLU A1197 SITE 2 AC1 9 MET A1199 ALA A1200 GLY A1202 LEU A1256 SITE 3 AC1 9 ASP A1270 CRYST1 51.891 57.502 103.986 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019271 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017391 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009617 0.00000